Research assistant at the Integrative Cell and Tissue Dynamics Research Group
Ref: RA-XT // Deadline: 17/10/2025
Ref: RA-XT // Deadline: 17/10/2025
Ref: SR_SS // Deadline: 15/12/2025
Amaya Hernández-Vega, a senior researcher at IBEC, will lead one of the two projects selected in the 2024 call for proposals from the Pasqual Maragall Research Programme, which is dedicated to funding research into Alzheimer’s disease and other neurodegenerative conditions. IBEC also celebrates the participation of Jordi Duran, an associate researcher from the Molecular and Cellular Neurobiotechnology group, who will collaborate on the second selected project.
L’administració de nanopartícules permet netejar toxines del cervell
Diseñan una novedosa técnica centrada en restaurar la salud vascular con inyecciones de nanopartículas. «En una hora se han empezado a ver resultados».
An international team co-led by the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital Sichuan University (WCHSU) was able to reverse Alzheimer’s in mice after only 3 injections with nanoparticles. The innovative approach to treating the disease focuses on restoring the normal function of the vasculature, rather than acting on neurons or other brain cells, as has usually been done until now. This achievement, published in the Signal Transduction and Targeted Therapy Journal, is a promising step towards an effective treatment for Alzheimer’s disease.
A new study reveals innovative nanotechnology that restored the function of the blood-brain barrier (BBB) to reverse Alzheimer’s in mice.
Injection of nanoparticles “reminds” blood-brain barrier to work properly, allowing brain cells to communicate again